HepatoScore-14: Measures of biological heterogeneity significantly improve prediction of hepatocellular carcinoma risk

BACKGROUND & AIMS: Therapeutic, clinical trial entry and stratification decisions for hepatocellular carcinoma (HCC) are made based on prognostic assessments, using clinical staging systems based on small numbers of empirically selected variables that insufficiently account for differences in bi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hepatology
Main Authors: Morris, Jeffrey S., Hassan, Manal M., Zohner, Ye Emma, Wang, Zeya, Xiao, Lianchun, Rashid, Asif, Haque, Abedul, Abdel-Wahab, Reham, Mohamed, Yehia A., Ballard, Karri L., Wolff, Robert A., George, Bhawana, Li, Liang, Allen, Genevera, Weylandt, Michael, Li, Donghui, Wang, Wenyi, Raghav, Kanwal, Yao, James, Amin, Hesham M., Kaseb, Ahmed Omar
Formato: Artigo
Idioma:Inglês
Publicado em: 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7956911/
https://ncbi.nlm.nih.gov/pubmed/32931023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.31555
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados